Moderna Inc (MRNA_KZ)

KASE
Currency in USD
Disclaimer
155.75
0.00(0.00%)
Delayed Data
Day's Range
155.75155.75
52 wk Range
131.93203.07
Bid/Ask
-
Prev. Close
155.75
Open
155.75
Day's Range
155.75-155.75
52 wk Range
131.93-203.07
Volume
0
Average Vol. (3m)
1
1-Year Change
29.68%
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
181.47
Upside +75.69%

People Also Watch

155.75
JNJ
-0.72%
434.99
NVDA
+0.95%
86.90
TSM
+0.57%
159.93
WMT
-1.61%
168.62
CVX
-1.15%

Moderna Inc Company Profile

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Income Statement